Pain modalities in the body and brain: Current knowledge and future perspectives

Neurosci Biobehav Rev. 2022 Aug:139:104744. doi: 10.1016/j.neubiorev.2022.104744. Epub 2022 Jun 15.

Abstract

Development and validation of pain biomarkers has become a major issue in pain research. Recent advances in multimodal data acquisition have allowed researchers to gather multivariate and multilevel whole-body measurements in patients with pain conditions, and data analysis techniques such as machine learning have led to novel findings in neural biomarkers for pain. Most studies have focused on the development of a biomarker to predict the severity of pain with high precision and high specificity, however, a similar approach to discriminate different modalities of pain is lacking. Identification of more accurate and specific pain biomarkers will require an in-depth understanding of the modality specificity of pain. In this review, we summarize early and recent findings on the modality specificity of pain in the brain, with a focus on distinct neural activity patterns between chronic clinical and acute experimental pain, direct, social, and vicarious pain, and somatic and visceral pain. We also suggest future directions to improve our current strategy of pain management using our knowledge of modality-specific aspects of pain.

Keywords: Biomarker; Functional neuroimaging; Modality specificity; Pain; Precision medicine.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Brain*
  • Humans
  • Machine Learning
  • Pain*

Substances

  • Biomarkers